Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.09

+0.4%

12:49 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (8367)	5/15/2003 12:01:30 PM
From: Icebrg	Read Replies (2) of 52153

Peter As I think I mentioned once, Medarex have two trials running with the combination of MDX-010 (an anti-CTLA-4 mAb) and some cancer vaccines. Neither of which are approved yet. One is sponsored by NCI and the other by the FDA Office of Orphan Products Development. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next